These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 5479813

  • 21. [Immunologic indices and their stimulation in suppurative diseases of the lungs].
    Lutsenko SM, Rybakov AI.
    Vestn Khir Im I I Grek; 1970 Nov; 105(11):12-4. PubMed ID: 4925944
    [No Abstract] [Full Text] [Related]

  • 22. [Early secondary suture in the treatment of acute suppurative diseases of the soft tissues].
    Grigorian AV, Gostishchev VK, Dzhalilov NG.
    Khirurgiia (Mosk); 1971 Jan; 47(1):60-4. PubMed ID: 4930587
    [No Abstract] [Full Text] [Related]

  • 23. [Use of proteolytic enzymes and ectericide in surgical treatment of suppuration].
    Kuzin EM.
    Vestn Khir Im I I Grek; 1977 Mar; 118(3):77-9. PubMed ID: 878201
    [Abstract] [Full Text] [Related]

  • 24. [Transcutaneous catheterization of major and lobar bronchi in treating suppurative diseases of the lungs].
    Dolmatov VF.
    Probl Tuberk; 1973 Mar; 51(1):33-6. PubMed ID: 4727156
    [No Abstract] [Full Text] [Related]

  • 25. [The use of proteolytic enzymes in patients with suppurative diseases of the pleura and lungs].
    Pomelov VS, Guznov GI.
    Sov Med; 1968 Jan; 31(1):69-74. PubMed ID: 5664555
    [No Abstract] [Full Text] [Related]

  • 26. [Complex therapy of patients with suppurative pulmonary disease].
    Litvinov AA, Laptev AN, Dmitriev AA.
    Vrach Delo; 1978 Apr; (4):41-2. PubMed ID: 664595
    [No Abstract] [Full Text] [Related]

  • 27. [Epidemiology and treatment of suppurative lung and pleural diseases in a children's hospital from 1936-1966 (399 cases)].
    Krepler P.
    Arch Kinderheilkd; 1968 Apr; 178(1):29-53. PubMed ID: 5718973
    [No Abstract] [Full Text] [Related]

  • 28. [Association of trypsin and chymotrypsin in pleural effusions of diverse etiology].
    De la Hoz J, Saboya L, Cárdenas M.
    Antioquia Med; 1966 Apr; 16(2):139-47. PubMed ID: 5946962
    [No Abstract] [Full Text] [Related]

  • 29. [A new focus for antimicrobial therapy].
    Garcia Herrera E.
    Cir Bucal; 1966 Apr; 1(7):173-6. PubMed ID: 5228361
    [No Abstract] [Full Text] [Related]

  • 30. The effect of a proteolytic enzyem mixture (Orenzyme-Forte) on experimentally induced pulpitis.
    Kieser J, Bridges P, Fatti LP, Austin JC, Cleaton-Jones P.
    Oral Surg Oral Med Oral Pathol; 1977 Feb; 43(2):300-5. PubMed ID: 401976
    [Abstract] [Full Text] [Related]

  • 31. Preliminary study on the effects of combined hydrolytic enzyme agents on mouse Krebs-2 carcinoma.
    Gurkoff J, McCabe DL.
    J Am Osteopath Assoc; 1974 Apr; 73(8):672-3. PubMed ID: 4494008
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical contribution to the use of oral antibiotic and enzyme therapy].
    Ghislandi E, Annoni S.
    Minerva Med; 1968 Feb 21; 59(15):811-5. PubMed ID: 5642245
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacologic agents.
    Aspen Emphysema Conf; 1965 Feb 21; 8():35-8. PubMed ID: 5900088
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Aerosol therapy with proteolytic enzymes and hormonal preparations in tuberculosis and nonspecific pulmonary diseases].
    Ginzburg ZI, Kniazhetskiĭ SM, Kolesnikova IS.
    Probl Tuberk; 1969 Feb 21; 47(5):48-52. PubMed ID: 5367971
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.